Vocal Cord Dysfunction (VCD)

Vocal cord dysfunction (VCD) — also called inducible laryngeal obstruction (ILO) or paradoxical vocal fold motion (PVFM) — is a condition in which the vocal cords close abnormally during inhalation instead of opening, causing sudden breathing difficulty that closely mimics asthma. It is significantly underdiagnosed and leads to years of unnecessary steroid and bronchodilator use in many patients.

Table of Contents

  1. What Is Vocal Cord Dysfunction?
  2. VCD vs. Asthma: Key Differences
  3. Common Triggers
  4. Diagnosis
  5. Spirometry and Flow-Volume Loops
  6. Laryngoscopy Findings
  7. Treatment and Speech Therapy
  8. Treating Underlying Triggers
  9. Anxiety and Psychological Management
  10. Acute Severe Episodes
  11. Prognosis and Long-Term Outlook
  12. References & Research
  13. Featured Videos

What Is Vocal Cord Dysfunction?

The vocal cords (vocal folds) normally open widely during inhalation to allow unrestricted airflow into the lungs. In VCD, the vocal folds paradoxically adduct — move toward each other — during inspiration, creating a partial or complete obstruction at the level of the larynx. This generates an audible, high-pitched wheeze known as stridor (typically inspiratory), shortness of breath, throat tightness, and a sensation of choking or smothering that can be terrifying for the patient.

Unlike asthma, where airflow obstruction occurs in the lower airways (bronchi and bronchioles), VCD is an upper airway problem originating at the larynx. The distinction matters enormously because the treatments are fundamentally different. Asthma responds to bronchodilators and inhaled corticosteroids; VCD does not. Misdiagnosis leads to repeated emergency room visits, escalating controller medications, and sometimes unnecessary intubation.

VCD was first systematically described by Christopher and Wood in 1975, though isolated case reports date to the 19th century. It disproportionately affects young women, athletes, and individuals with anxiety or a history of trauma, though it can occur at any age and in either sex.

VCD vs. Asthma: Key Differences

The single most important clinical clue is the lack of response to bronchodilators. A patient who arrives wheezing and dyspneic but shows no improvement after multiple albuterol nebulizations should immediately raise suspicion for VCD or a VCD-asthma overlap syndrome.

Differentiating Features

Common Triggers

VCD episodes can be provoked by a wide variety of stimuli that irritate or sensitize the larynx:

Physical Triggers

Reflux and Upper Airway Triggers

Psychological Triggers

Diagnosis

Diagnosing VCD requires combining a careful history, physical examination, and objective testing. Many patients carry a prior asthma diagnosis for years before VCD is recognized.

Clinical History

Key historical features supporting VCD include: episodic inspiratory difficulty rather than expiratory difficulty; throat tightness as the predominant symptom; triggers such as exercise, strong smells, or cold air; failure to respond to inhaled bronchodilators; normal or near-normal pulmonary function testing between episodes; and rapid symptom resolution (often within minutes, sometimes with specific breathing maneuvers).

Physical Examination

Between episodes, the examination is typically normal. During an episode, inspiratory stridor may be heard over the larynx/neck, while the chest is clear to auscultation — a finding inconsistent with asthma. Oxygen saturation is usually preserved.

Spirometry and Flow-Volume Loops

Spirometry performed during a symptomatic episode is the most accessible objective test for VCD and can be diagnostic when interpreted by a clinician familiar with the pattern.

The Inspiratory Loop Truncation Sign

In normal spirometry, the flow-volume loop forms a smooth, rounded shape for both inspiration and expiration. VCD produces a characteristic truncation (flattening) of the inspiratory limb of the flow-volume loop. This reflects variable extrathoracic upper airway obstruction — the hallmark of VCD.

It is critical to note that spirometry performed between episodes may be entirely normal, which is why the test should ideally be performed during or shortly after a symptomatic episode.

Laryngoscopy Findings

Direct visualization of the vocal cords during an episode is the gold standard for diagnosing VCD. Flexible nasopharyngolaryngoscopy (NPL) is the preferred technique as it can be performed at the bedside or in the clinic without sedation.

Classic Laryngoscopic Appearance

Provocative testing — having the patient exercise, inhale a strong scent, or hyperventilate — may be necessary to elicit findings when the patient is asymptomatic at rest. Continuous laryngoscopy during exercise (CLE) test protocols are increasingly used in sports medicine centers.

Treatment and Speech Therapy

Speech-language pathology (SLP) is the cornerstone of VCD treatment. The goal is to restore voluntary control over laryngeal movement and habituate a relaxed, open-glottis breathing pattern that the patient can deploy during acute episodes.

Laryngeal Control Techniques

The speech therapist teaches a set of specific respiratory retraining maneuvers:

Buteyko Breathing Method

The Buteyko method — a systematic approach to reducing breathing volume and restoring nasal breathing predominance — has shown benefit in VCD and comorbid asthma. Reduced minute ventilation decreases the drying and cooling of laryngeal mucosa and lowers the reflex sensitivity of laryngeal mechanoreceptors. Pilot studies and clinical series support its use as an adjunct to standard SLP therapy.

Number of Sessions

Most patients see significant improvement within 3 to 6 SLP sessions, though maintenance and exercise-specific training may require additional visits. Home practice of the learned techniques is essential.

Treating Underlying Triggers

SLP addresses the laryngeal behavior, but failing to treat underlying drivers leads to relapse. A systematic evaluation of contributing conditions is mandatory.

GERD and Laryngopharyngeal Reflux (LPR)

LPR is present in a significant minority of VCD patients and is a powerful perpetuating factor. Unlike GERD, LPR often occurs without heartburn — the patient may only report chronic throat clearing, hoarseness, or globus sensation. Empirical treatment with twice-daily proton pump inhibitors (PPIs) for 8 to 12 weeks is reasonable when LPR is suspected. Dietary modifications (avoid late meals, alcohol, caffeine, fatty/spicy foods), head-of-bed elevation, and weight loss when applicable are important adjuncts. Some evidence supports alginate preparations for LPR specifically.

Postnasal Drip (PND)

Allergic rhinitis and chronic sinusitis should be evaluated and treated aggressively. Options include intranasal corticosteroid sprays, antihistamines, saline nasal irrigation (nasal rinse), and allergen immunotherapy where indicated. Controlling PND can dramatically reduce the frequency of VCD episodes.

Vocal Hygiene

Patients should be counseled on vocal hygiene: adequate hydration, humidification of indoor air, avoiding throat clearing (replace with a gentle swallow or silent cough), reducing or eliminating voice abuse, and avoiding known irritant exposures.

Anxiety and Psychological Management

The relationship between VCD and anxiety is bidirectional and complex. Anxiety lowers the threshold for VCD episodes through hyperventilation, increased laryngeal muscle tension, and heightened sensory vigilance. Conversely, the terrifying and unpredictable nature of VCD episodes generates anticipatory anxiety that itself becomes a trigger.

Cognitive Behavioral Therapy (CBT)

CBT is the most evidence-based psychological intervention for anxiety-related VCD. It addresses catastrophic interpretations of breathing sensations, avoidance of trigger situations, hypervigilance, and the anxiety-VCD feedback loop. Several pilot RCTs support integration of CBT with SLP therapy as superior to either alone.

Biofeedback

Respiratory biofeedback — providing real-time visual feedback of breathing rate, CO2 levels (capnography), or chest wall movement — helps patients consciously regulate their breathing pattern and recognize precursors to episodes.

Screening and Referral

A validated screening tool such as the Patient Health Questionnaire (PHQ-9) for depression and the Generalized Anxiety Disorder-7 (GAD-7) for anxiety should be used. Patients with significant scores should be referred to a mental health professional experienced with somatoform breathing disorders. A small subset of patients, particularly those with trauma history, may benefit from trauma-focused psychotherapy.

Acute Severe Episodes

Most VCD episodes resolve spontaneously or with the patient's own learned breathing techniques within minutes. However, severe or prolonged episodes may require medical intervention.

First-Line: Coached Breathing

The most effective immediate intervention is calm, directive coaching of the patient through laryngeal control techniques. A calm, authoritative presence instructing the patient to "breathe slowly through pursed lips," "exhale first," or "relax your throat" is often sufficient and should always be attempted before pharmacological measures.

Heliox

Heliox (a mixture of 70–80% helium and 20–30% oxygen) is the most evidence-supported pharmacological option for acute VCD. Helium is a low-density gas; substituting it for nitrogen reduces the turbulent flow resistance at the laryngeal obstruction, reducing the work of breathing and allowing the episode to abort. It is inhaled via a tight-fitting non-rebreather mask and typically produces rapid symptom relief.

What to Avoid

Prognosis and Long-Term Outlook

VCD is a highly treatable condition when correctly identified. Most patients achieve significant or complete episode resolution with appropriate speech therapy combined with treatment of underlying triggers. Key prognostic factors include:

Long-term outcomes research demonstrates that the majority of patients who complete a full multimodal treatment program remain largely asymptomatic at two-year follow-up.


References & Research

Key Research Papers

  1. Christopher KL, Wood RP 2nd, Eckert RC, Blager FB, Raney RA, Souhrada JF. Vocal-cord dysfunction presenting as asthma. N Engl J Med. 1983;308(26):1566-1570. PMID 6855723
  2. Balkissoon R, Kenn K. Asthma: vocal cord dysfunction (VCD) and other dysfunctional breathing disorders. Semin Respir Crit Care Med. 2012;33(6):595-605. PMID 23047307
  3. Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics. 2007;120(4):855-864. PMID 17908773
  4. Halvorsen T, Walsted ES, Bucca C, et al. Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement. Eur Respir J. 2017;50(3):1602221. PMID 28893868
  5. Morris MJ, Christopher KL. Diagnostic criteria for the classification of vocal cord dysfunction. Chest. 2010;138(5):1213-1223. PMID 20382696
  6. Walsted ES, Famowoyi AI, Hull JH, et al. Continuous laryngoscopy during exercise: a reliable diagnostic method for exercise-induced laryngeal obstruction. Laryngoscope. 2017;127(11):2505-2510. PMID 28369929
  7. Blager FB. Paradoxical vocal fold movement: diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2000;8(3):180-185. PMID 10805633
  8. Patel RR, Venediktov R, Schooling T, Wang B. Evidence-based systematic review: Effects of speech-language pathology treatment for individuals with paradoxical vocal fold motion. Am J Speech Lang Pathol. 2015;24(3):566-584. PMID 25909839
  9. Gimenez LM, Zafra H. Vocal cord dysfunction: an update. Ann Allergy Asthma Immunol. 2011;106(4):267-274. PMID 21457876
  10. Martin RJ, Blager FB, Gay ML, Wood RP. Paradoxic vocal cord motion in presumed asthmatics. Semin Respir Med. 1987;8(4):332-337. PMID 3296694
  11. Reitz JR, Gorini C, Bhatt JM. Heliox for vocal cord dysfunction: a systematic review. Laryngoscope Investig Otolaryngol. 2021;6(2):285-292. PMID 33869729
  12. Powell DM, Karanfilov BI, Beechler KB, Treole K, Trudeau MD, Forrest LA. Paradoxical vocal cord dysfunction in juveniles. Arch Otolaryngol Head Neck Surg. 2000;126(1):29-34. PMID 10628706

Back to Table of Contents


Research Papers

The following PubMed topic searches retrieve current peer-reviewed literature on Vocal Cord Dysfunction. Each link opens a live PubMed query.

  1. Vocal cord dysfunction paradoxical
  2. Inducible laryngeal obstruction
  3. VCD asthma misdiagnosis
  4. Exercise-induced laryngeal obstruction
  5. Speech therapy vocal cord dysfunction
  6. Buteyko breathing vocal cord
  7. Heliox vocal cord dysfunction
  8. Laryngopharyngeal reflux VCD
  9. Flow-volume loop inspiratory truncation
  10. Paradoxical vocal fold motion anxiety

Back to Table of Contents


Connections

Back to Table of Contents